IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,858,355 | +64531.0% | 3,705,133 | 0.0% | 0.90% | -25.9% |
| Q2 2023 | $26,084 | +15.2% | 3,705,133 | 0.0% | 1.21% | +8.8% |
| Q1 2023 | $22,638 | -99.8% | 3,705,133 | +146.2% | 1.11% | +119.3% |
| Q4 2022 | $9,617,800 | -48.1% | 1,505,133 | -22.2% | 0.51% | -51.4% |
| Q3 2022 | $18,539,000 | -13.2% | 1,935,133 | 0.0% | 1.04% | -22.9% |
| Q2 2022 | $21,364,000 | -33.7% | 1,935,133 | 0.0% | 1.35% | -18.3% |
| Q1 2022 | $32,220,000 | +53.4% | 1,935,133 | +75.9% | 1.66% | +102.9% |
| Q4 2021 | $20,999,000 | -22.6% | 1,100,000 | 0.0% | 0.82% | -13.8% |
| Q3 2021 | $27,126,000 | +394.1% | 1,100,000 | +450.0% | 0.95% | +292.9% |
| Q2 2020 | $5,490,000 | – | 200,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |